Literature DB >> 12807718

Radiation-induced deletions in the 5' end region of Notch1 lead to the formation of truncated proteins and are involved in the development of mouse thymic lymphomas.

Hideo Tsuji1, Hiroko Ishii-Ohba, Hideki Ukai, Takanori Katsube, Toshiaki Ogiu.   

Abstract

Notch1 protein is a transmembrane receptor that directs various cell fate decisions. Active forms of Notch1 consisting of a transmembrane domain and an intracellular domain (Notch1TM) or only an intracellular domain (Notch1IC) function as oncoproteins. To elucidate the effect of Notch1 abnormalities in radiation-induced lymphomagenesis, we determined the structure of the Notch1 gene and examined the frequency and the sites of Notch1 rearrangements in radiation-induced mouse thymic lymphomas. The Notch1 gene consists of 37 exons, including three exons upstream of the previously reported exon 1. The transcript starting from exon 1 was the major transcript whereas the transcripts read upstream from exon 1a, in which amino acid sequences in the N-terminal region were changed, were minor. More than 50% of radiation-induced thymic lymphomas exhibited Notch1 rearrangements, suggesting that Notch1 acts as a major oncogene in radiation-induced lymphomagenesis. We identified three rearranged sites: novel sites in the 5' end region encompassing exons 1 and 2, the previously identified juxtamembrane extracellular region, and the 3' end region. The 5' deletion and the insertion of murine leukemia virus in the juxtamembrane region led to the production of abnormal transcripts starting from cryptic transcription start sites located halfway through the Notch1 gene and resulted in transcripts lacking most of the extracellular domain. As a result of these rearrangements, truncated Notch1 polypeptides resembling Notch1TM or Notch1IC were formed. In contrast, the 3' deletion led to the production of a C-terminal PEST motif-deleted transcript. The downstream target gene Hes1 was transcribed in a lymphoma with insertion of murine leukemia virus, but not in a lymphoma with a 5' deletion. These results indicate that in addition to Hes1 expression, other Notch1 pathway(s) have a role in thymic lymphomagenesis and suggest the presence of a novel mechanism for oncogenic activation of Notch1 by 5' deletion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807718     DOI: 10.1093/carcin/bgg071

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  22 in total

1.  An activating intragenic deletion in NOTCH1 in human T-ALL.

Authors:  J Erika Haydu; Kim De Keersmaecker; Mary Kaye Duff; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Adolfo Ferrando
Journal:  Blood       Date:  2012-04-17       Impact factor: 22.113

2.  Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Authors:  Todd D Ashworth; Warren S Pear; Mark Y Chiang; Stephen C Blacklow; Jérôme Mastio; Lanwei Xu; Michelle Kelliher; Philippe Kastner; Susan Chan; Jon C Aster
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

3.  Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape.

Authors:  Courtney J Fleenor; Andriy Marusyk; James DeGregori
Journal:  Cell Cycle       Date:  2010-08-07       Impact factor: 4.534

Review 4.  Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities.

Authors:  Jon C Aster
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

5.  Regulation of notch1 signaling by nrf2: implications for tissue regeneration.

Authors:  Nobunao Wakabayashi; Soona Shin; Stephen L Slocum; Elin S Agoston; Junko Wakabayashi; Mi-Kyoung Kwak; Vikas Misra; Shyam Biswal; Masayuki Yamamoto; Thomas W Kensler
Journal:  Sci Signal       Date:  2010-07-13       Impact factor: 8.192

6.  Mutations in NOTCH1 cause Adams-Oliver syndrome.

Authors:  Anna-Barbara Stittrich; Anna Lehman; Dale L Bodian; Justin Ashworth; Zheyuan Zong; Hong Li; Patricia Lam; Alina Khromykh; Ramaswamy K Iyer; Joseph G Vockley; Rajiv Baveja; Ermelinda Santos Silva; Joanne Dixon; Eyby L Leon; Benjamin D Solomon; Gustavo Glusman; John E Niederhuber; Jared C Roach; Millan S Patel
Journal:  Am J Hum Genet       Date:  2014-08-14       Impact factor: 11.025

Review 7.  Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.

Authors:  Masahiro Onozawa; Peter D Aplan
Journal:  Genes Chromosomes Cancer       Date:  2012-02-15       Impact factor: 5.006

Review 8.  Notch signaling in leukemia.

Authors:  Jon C Aster; Warren S Pear; Stephen C Blacklow
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

9.  Irradiation alters selection for oncogenic mutations in hematopoietic progenitors.

Authors:  Andriy Marusyk; Matias Casás-Selves; Curtis J Henry; Vadym Zaberezhnyy; Jelena Klawitter; Uwe Christians; James DeGregori
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

Review 10.  Evolved Cellular Mechanisms to Respond to Genotoxic Insults: Implications for Radiation-Induced Hematologic Malignancies.

Authors:  Courtney J Fleenor; Kelly Higa; Michael M Weil; James DeGregori
Journal:  Radiat Res       Date:  2015-09-28       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.